Divi's Laboratories Limited (BOM:532488)
6,169.15
-19.05 (-0.31%)
At close: Feb 13, 2026
Divi's Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | - | 4,150 | 3,630 | 1,700 | 12,148 | 20,303 |
Short-Term Investments | - | 31,120 | 33,350 | 39,630 | 15,269 | 505 |
Cash & Short-Term Investments | 32,610 | 35,270 | 36,980 | 41,330 | 27,417 | 20,808 |
Cash Growth | -9.47% | -4.62% | -10.53% | 50.75% | 31.76% | 102.91% |
Accounts Receivable | - | 27,310 | 21,560 | 17,930 | 24,239 | 16,765 |
Other Receivables | - | 2,470 | 2,050 | 1,410 | 1,045 | 1,018 |
Receivables | - | 29,780 | 23,610 | 19,340 | 25,283 | 17,783 |
Inventory | - | 32,360 | 31,840 | 30,000 | 28,286 | 21,452 |
Prepaid Expenses | - | 370 | 360 | 260 | 270.9 | 225 |
Other Current Assets | - | 3,030 | 3,960 | 2,190 | 2,258 | 1,479 |
Total Current Assets | - | 100,810 | 96,750 | 93,120 | 83,515 | 61,747 |
Property, Plant & Equipment | - | 64,600 | 55,130 | 49,290 | 47,875 | 44,095 |
Long-Term Investments | - | 650 | 820 | 770 | 720.1 | 0.1 |
Other Intangible Assets | - | 40 | 40 | 50 | 74.9 | 49.5 |
Long-Term Deferred Tax Assets | - | 110 | 100 | 140 | 144.7 | 32.3 |
Other Long-Term Assets | - | 3,110 | 1,860 | 1,020 | 1,418 | 1,816 |
Total Assets | - | 169,320 | 154,700 | 144,390 | 133,747 | 107,741 |
Accounts Payable | - | 9,100 | 8,240 | 7,620 | 7,957 | 7,632 |
Accrued Expenses | - | 3,460 | 2,440 | 2,550 | 3,235 | 2,486 |
Short-Term Debt | - | 20 | - | - | - | 3.5 |
Current Portion of Leases | - | - | 10 | 10 | 8.2 | 7.9 |
Current Income Taxes Payable | - | - | 430 | 20 | 16.8 | 59.8 |
Current Unearned Revenue | - | 10 | 10 | 10 | 7.6 | 6.4 |
Other Current Liabilities | - | 1,930 | 1,650 | 800 | 731.3 | 929.3 |
Total Current Liabilities | - | 14,520 | 12,780 | 11,010 | 11,956 | 11,125 |
Long-Term Leases | - | 20 | 20 | 30 | 28.7 | 36.9 |
Long-Term Deferred Tax Liabilities | - | 5,090 | 5,820 | 5,370 | 4,214 | 3,381 |
Other Long-Term Liabilities | - | - | 370 | 310 | 267.1 | 252.5 |
Total Liabilities | - | 19,630 | 18,990 | 16,720 | 16,465 | 14,795 |
Common Stock | - | 530 | 530 | 530 | 530.9 | 530.9 |
Additional Paid-In Capital | - | 800 | 800 | 800 | 798.8 | 798.8 |
Retained Earnings | - | 148,050 | 134,120 | 126,090 | 115,797 | 91,480 |
Comprehensive Income & Other | - | 310 | 260 | 250 | 155.1 | 136.3 |
Shareholders' Equity | 154,130 | 149,690 | 135,710 | 127,670 | 117,282 | 92,946 |
Total Liabilities & Equity | - | 169,320 | 154,700 | 144,390 | 133,747 | 107,741 |
Total Debt | 900 | 40 | 30 | 40 | 36.9 | 48.3 |
Net Cash (Debt) | 31,710 | 35,230 | 36,950 | 41,290 | 27,380 | 20,760 |
Net Cash Growth | -11.77% | -4.66% | -10.51% | 50.80% | 31.89% | 110.41% |
Net Cash Per Share | 119.44 | 132.71 | 139.19 | 155.54 | 103.14 | 78.20 |
Filing Date Shares Outstanding | 265.24 | 265.47 | 265.47 | 265.47 | 265.47 | 265.47 |
Total Common Shares Outstanding | 265.24 | 265.47 | 265.47 | 265.47 | 265.47 | 265.47 |
Working Capital | - | 86,290 | 83,970 | 82,110 | 71,560 | 50,623 |
Book Value Per Share | 580.95 | 563.87 | 511.21 | 480.92 | 441.79 | 350.12 |
Tangible Book Value | 154,090 | 149,650 | 135,670 | 127,620 | 117,207 | 92,897 |
Tangible Book Value Per Share | 580.80 | 563.72 | 511.06 | 480.73 | 441.51 | 349.93 |
Land | - | 2,020 | 1,950 | 1,940 | 1,727 | 1,715 |
Machinery | - | 55,000 | 48,630 | 45,770 | 39,860 | 33,535 |
Construction In Progress | - | 10,220 | 7,780 | 2,120 | 4,699 | 7,106 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.